Discontinuation report PMS-BOSENTAN
Report ID | 135510 |
Drug Identification Number | 02383012 |
Brand name | PMS-BOSENTAN |
Common or Proper name | BOSENTAN |
Company Name | PHARMASCIENCE INC |
Market Status | MARKETED |
Active Ingredient(s) | BOSENTAN |
Strength(s) | 62.5MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 4x15 |
ATC code | C02KX |
ATC description | OTHER ANTIHYPERTENSIVES |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | |
Actual discontinuation date | 2021-03-10 |
Remaining supply date | 2021-03-10 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | Demand transferred to 5760602787 pms-BOSENTAN 62.5mg COMP ALV 10X6 |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 6111 ROYALMOUNT AVE MONTREAL, QUEBEC CANADA H4P 2T4 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2021-03-11 | English | Compare |
v2 | 2021-03-11 | French | Compare |
v3 | 2021-03-19 | English | Compare |
v4 | 2021-03-19 | French | Compare |
Showing 1 to 4 of 4